Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors

Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors

Guardado en:
Detalles Bibliográficos
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/3507472f96914934b6c4a2a7122da768
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3507472f96914934b6c4a2a7122da768
record_format dspace
spelling oai:doaj.org-article:3507472f96914934b6c4a2a7122da7682021-12-05T09:30:05ZCorrection: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors10.1136/jitc-2021-003005corr12051-1426https://doaj.org/article/3507472f96914934b6c4a2a7122da7682021-11-01T00:00:00Zhttps://jitc.bmj.com/content/9/11/e003005corr1.fullhttps://doaj.org/toc/2051-1426BMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
format article
title Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
title_short Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
title_full Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
title_fullStr Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
title_full_unstemmed Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
title_sort correction: gb1275, a first-in-class cd11b modulator: rationale for immunotherapeutic combinations in solid tumors
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/3507472f96914934b6c4a2a7122da768
_version_ 1718372547583541248

Ejemplares similares